Patent · US Expired

Neurogene

US5817784A · kind A · utility

3Cited by
0References
18Claims
0Family size

Assignees

Inventors

Key dates

Filing dateAug 9, 1996
Grant dateOct 6, 1998
Priority date
Expiry dateAug 9, 2016

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S530/855
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed are DNA and amino acid sequences for a novel polypeptide termed Neuritin which is expressed primarily in selected regions of the brain.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.